STAT - Reporting from the frontiers of health and medicine
A fabulous narrative of twists and turns and collaborations across multiple nonprofit institutions, companies, governments. As we debate drug pricing and R/D timelines, often cynically, this is a nice example of staying focused on the problem and bringing assets together for a solution. Well done! Great read to start 2020.
Also in Industry News
How to decide whether or not to start treatment for prostate cancer?
How to decide whether or not to start treatment for prostate cancer?
Analysis of the SARS-CoV-2 proteome via visual tools
Analysis of the SARS-CoV-2 proteome via visual tools
$65m investment increases British Patient Capital’s exposure to life sciences and health technology
$65m investment increases British Patient Capital’s exposure to life sciences and health technology